Ruth is currently a Clinical Senior Lecturer in the Preventive Neurology Unit at the Wolfson Institute of Preventive Medicine, QMUL, and an Honorary Consultant Neurologist at BartsHealth NHS Trust. She studied medicine at Clare College, Cambridge and UCL, before completing medical and neurology training in London, Birmingham and Sussex. She completed her PhD in 2013, which examined the genetic and environmental determinants of MS risk. This was supported by an ABN/MS Society Clinical Research Training Fellowship and a Brain Entry Scholarship. She was also awarded an AAN International Scholarship Award for her research.

Her main research interests are around the early identification and epidemiology of multiple sclerosis, with a particular focus on genetic and environmental risk factors including Epstein Barr virus infection and vitamin D. She is also working on how these may affect downstream morbidity in MS, with a particular focus on bone health. A further research interest is pharmacovigilance and treatment-associated risk in MS, and she is currently involved in setting up UK-wide studies to study this further.

Dr Ruth Dobson at ‘MS Service Provision in the UK; the Way Forward’, Birmingham November 2018

MS Variance: Web-based Pharmacovigilance as an Opportunity to Track Variation in MS Service Provision
→ More videos from this event

Listen to this presentation:

→ More podcasts from this event

Webinar: Pregnancy – What should we advise our patients during the COVID-19 pandemic? | MS Academy

→ More COVID19 webinars